Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
05/09/1985 | WO1985001958A1 Production of heterodimeric human fertility hormones |
05/09/1985 | WO1985001941A1 Method for the purification and isolation of blood clotting proteins using conformation specific antibodies |
05/08/1985 | EP0140864A1 Externalization of products of bacteria |
05/08/1985 | EP0140689A2 Hybrid cell lines producing monoclonal antibodies directed against treponema and use thereof for immuno-diagnosis of treponemal infections |
05/08/1985 | EP0140127A1 Process for the preparation of immune interferon |
05/08/1985 | EP0140084A1 Process for the preparation of insulin derivatives with a C-terminally elongated B-chain, basically modified insulin derivatives, compositions containing them and their use |
05/07/1985 | US4515891 Process for the production of disaccharide-tripeptide and disaccharide-tetrapeptide |
05/07/1985 | CA1186629A1 Biologically active substance, process for preparing the substance and immunoactive composition |
05/02/1985 | EP0139501A2 The manufacture and expression of genes for thaumatin |
05/02/1985 | EP0139417A1 Vaccines based on membrane bound proteins and process for making them |
05/02/1985 | EP0139416A2 Molecularly cloned diagnostic product and method of use |
05/02/1985 | EP0139389A1 Antiidiotypic monoclonal antibody reagents and immunoassays employing antiidiotypic monoclonal antibody reagents |
05/02/1985 | EP0139383A1 Method for expressing foreign genes in schizosaccharomyces pombe and the use in therapeutic formulations of the products, DNA constructs and transformant strains of schizosaccharomyces pombe usable in such method and their preparation |
05/02/1985 | EP0139216A2 Adult T cell leukemia virus antigen peptide |
04/30/1985 | US4514498 Urogential disorders |
04/30/1985 | CA1186256A1 Use of isotropic, porous-wall polymeric membrane, hollow-fibers for culture of microbes and other living cells |
04/25/1985 | WO1985001746A1 The manufacture and expression of genes for thaumatin |
04/25/1985 | WO1985001659A1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
04/24/1985 | EP0138377A1 Lewis blood group phenotype assay |
04/24/1985 | EP0138222A2 Preparation of monoclonal anti-protein C antibodies |
04/24/1985 | EP0138167A1 Method for purification of HBs antigen |
04/24/1985 | EP0138101A1 Genetically engineered organisms expressing surface proteins of T. Cruzi |
04/24/1985 | EP0138087A1 Immune interferon and method for its purification |
04/24/1985 | EP0137869A2 Derived nisin producing microorganisms, method of production and use and products obtained thereby |
04/24/1985 | EP0137822A1 Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems. |
04/23/1985 | CA1185909A1 Heteropolysaccharide s-194 |
04/17/1985 | EP0137691A1 Production of immune interferon and its mRNA |
04/17/1985 | EP0137689A1 GRF analogs |
04/17/1985 | EP0137657A2 Monoclonal antibodies |
04/17/1985 | EP0137633A1 Method of expressing alpha-1-antitrypsin in bacteria and its use in therapeutic formulations, and vectors and bacteria for such method and their production |
04/17/1985 | EP0137345A2 Membrane-associated proteins (MP-2), process for obtaining them and their application |
04/16/1985 | US4511505 Threonine derivatives |
04/11/1985 | WO1985001517A1 PRODUCTION OF cDNA REPRESENTING HEPATITIS A VIRAL SEQUENCES |
04/11/1985 | WO1985001515A1 T-cell growth factor of the gibbon ape |
04/10/1985 | EP0136907A2 A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom |
04/10/1985 | EP0136835A2 Process for the preparation of antibody compositions of therapeutic agents having an extended serum half-life |
04/10/1985 | EP0136829A2 Improved expression vector and use thereof |
04/10/1985 | EP0136620A1 Homogeneous immune interferon fragment |
04/10/1985 | EP0136490A2 DNA plasmids |
04/10/1985 | EP0136472A1 Production of secretin |
04/09/1985 | US4510132 Compounds for use in antibacterial therapy |
04/09/1985 | CA1185178A1 Method for purifying interferon |
04/03/1985 | EP0136215A2 Method and materials for development of immunological responses protective against malarial infection |
04/03/1985 | EP0135712A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
04/02/1985 | US4508643 Human chorionic govadotropin; low cross-reactivity |
04/02/1985 | CA1184899A1 Glycoprotein |
04/02/1985 | CA1184862A1 Filtration method for cell produced antiviral substances |
03/28/1985 | WO1985001296A1 Yeast hybrid vectors |
03/27/1985 | EP0135347A1 Human renin and cDNA encoding therefor |
03/27/1985 | EP0135159A2 Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same |
03/27/1985 | EP0135073A2 Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
03/27/1985 | EP0134803A1 Monoclonal antibody |
03/20/1985 | EP0134673A1 Improved plasmid vector and use thereof |
03/20/1985 | EP0134631A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
03/20/1985 | EP0134552A2 Monoclonal antibody with a high affinity for digoxin |
03/20/1985 | EP0134479A1 Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
03/20/1985 | EP0134385A2 A protein having cell growth stimulating action, composition thereof and method for producing the same |
03/20/1985 | EP0134247A1 Protein with oncostatic effect, process for its preparation, and oncostatic drug containing it |
03/14/1985 | WO1985001067A1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
03/14/1985 | WO1985001066A1 Process for producing peptide |
03/14/1985 | WO1985000977A1 Vaccine and antigen against paludism and preparation process thereof |
03/14/1985 | WO1985000976A1 Method and materials for development of immunological responses protective against malarial infection |
03/14/1985 | WO1985000974A1 Antibody compositions of therapeutic agents having an extended serum half-life |
03/13/1985 | EP0134085A1 DNA encoding a GRF precursor |
03/13/1985 | EP0134048A1 Molecular cloning and expression in industrial microorganism species |
03/12/1985 | US4504644 Sunscreen agents |
03/12/1985 | US4504394 Process for the treatment of organic fall-out products |
03/05/1985 | US4503048 Pyridine soluble extract of a microorganism |
03/05/1985 | CA1183470A1 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
03/05/1985 | CA1183469A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells, antibody, and method |
03/05/1985 | CA1183451A1 Method for producing a csap tryptic peptide and anti- csap antibodies |
02/28/1985 | WO1985000832A1 Production of streptococal m protein immunogens and molecular probes |
02/28/1985 | WO1985000829A1 Dna plasmids |
02/28/1985 | WO1985000807A1 Polypeptide-induced monoclonal antibodies to oncoproteins |
02/27/1985 | EP0133599A2 Vaccines and compositions against hepatitis B viral infections |
02/27/1985 | EP0133551A2 Monoclonal antibody which recognizes a structure which is common to the human interleukin-2 (TCGF) and to the light chain lambda of human immunoglobulin, and hybridoma cell lines producing this monoclonal antibody |
02/27/1985 | EP0133540A1 Receptor assays using labeled monoclonal anti-idiotypic antibodies |
02/26/1985 | US4501693 Hydrolyzing proteoglycans with lysozyme |
02/26/1985 | CA1183092A2 Production of yeast cells at high cell densities |
02/20/1985 | EP0133403A2 Nucleotide sequence coding for the signal peptide of diphteria toxin, vector containing this nucleotide sequence, its use in the transformation of microorganisms and peptide compositions obtained therefrom. |
02/20/1985 | EP0133284A2 Process for isolating and purifying interferon |
02/20/1985 | EP0133282A1 Preparation of acidamide-carboxy-terminal polypeptides |
02/20/1985 | EP0051071B1 Tryptophane derivative and process for preparing same |
02/13/1985 | EP0133079A2 Process for the separation and isolation of nosiheptide |
02/13/1985 | EP0133044A1 Stabilising foreign proteins, and plasmids for use therein |
02/13/1985 | EP0132770A1 Insulin derivatives, processes for their preparation, their use and pharmaceutical compositions for the treatment of diabetes mellitus |
02/13/1985 | EP0132732A2 Homologues from aprotinine whose lys 15 amino acid is substituted by other amino acids, process for their preparation and their use as medicaments |
02/13/1985 | EP0132488A2 Rat antibody to human chorionic gonadotropin |
02/12/1985 | US4499189 Bacteria carrying plasmid having temperature dependent plasmid copy number |
02/12/1985 | US4499014 Method for purifying gamma-interferon |
02/12/1985 | CA1182447A1 Derivatives of actaplanin |
02/12/1985 | CA1182407A1 MICROBIOLOGICAL SYNTHESIS OF .beta. ENDORPHIN |
02/12/1985 | CA1182406A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody, and methods |
01/31/1985 | WO1985000382A1 Molecular cloning and expression in industrial microorganism species |
01/31/1985 | WO1985000381A1 Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production |
01/31/1985 | WO1985000369A1 Hybrid dna synthesis of epidermal growth factor |
01/30/1985 | EP0132349A2 Antibiotic called "chloropolysporin", a process for its preparation, and its therapeutic and veterinary use |
01/29/1985 | CA1181702A1 Hybrid cell line for producing monoclonal antibody to a human thymocyte antigen, antibody, and methods |
01/23/1985 | EP0132125A2 A protein having antitumor activity |
01/23/1985 | EP0131878A2 Process for producing human monoclonal antibodies |